Up And Up Fiber Therapy Powder
NDC Package 11673-669-91
Package Information
Up And Up Fiber Therapy (psyllium husk) powders is a medication used to treat constipation. This formulation utilizes a powder delivery system. Marketed by Target Corporation, this product is identified by NDC 11673-669 and is authorized under FDA application M007.
Identification & Billing
- RxCUI: 824586 - psyllium 3.4 GM Powder for Oral Suspension
- RxCUI: 824586 - psyllium 3400 MG Powder for Oral Suspension
Clinical Specifications
- Oral - Administration to or by way of the mouth.
- Oral - Administration to or by way of the mouth.
Regulatory & Marketing
Hierarchy Structure
- 11673 - Target Corporation
- 11673-669 - Up And Up Fiber Therapy
- 11673-669-91 - 660 g in 1 BOTTLE
- 11673-669 - Up And Up Fiber Therapy
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (11673-669). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 11673-669-91 identifies a specific commercial package of 660 g in 1 bottle of Up And Up Fiber Therapy, a human over the counter drug labeled by Target Corporation. This product is billed per "GM" gram and contains an estimated amount of 660 billable units per package. This powder is formulated for oral use and contains psyllium husk as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Target Corporation on October 26, 2015. The current certification is valid through December 31, 2026.
What are the primary indications for this medication?
This medication is used to treat constipation. It increases the bulk in your stool, an effect that helps to cause movement of the intestines. It also works by increasing the amount of water in the stool, making the stool softer and easier to pass. Psyllium, one type of bulk-forming laxative, has also been used along with a proper diet to treat high cholesterol.
How is this Target Corporation product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 11673066991. Quantities are measured in per "gm or gram", products billed per gram are products measured by weight.. There are 660 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.